BD - GeneOhm - News

News

November 20, 2008
BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene

July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections

June 10, 2008
BD Celebrates Opening of New Manufacturing Center in Québec

April 07, 2008
Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU

March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates

January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens

December 18, 2007
UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent

November 05, 2007
BD Sponsors New Tool to Combat MRSA Infections in Hospitals

October 04, 2007
BD GeneOhm's Flagship Client, Evanston Northwestern Healthcare, Receives Prestigious Patient Safety Award from the NQF and the Joint Commission for its MRSA Prevention Program

May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

April 25, 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures

March 12, 2007
Evanston Northwestern Healthcare Study Reveals Who is Most at Risk for Carrying MRSA (PDF)

March 12, 2007
Evanston Northwestern Healthcare Study Shows Benefit of Universal Surveillance (PDF)

Site Map Privacy \| Terms & Conditions \| Permission Request \| Trademarks BD Worldwide
BD 1 Becton Drive Franklin Lakes, NJ USA 07417 201.847.6800
Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2008 BD